NA
DXCM icon

NewEdge Advisors’s DexCom DXCM Stock Holding History

NewEdge Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Buy
29,455
+2,560
+10% +$171K 0.01% 1224
2026
Q1 		$1.69M Sell
26,895
-3,302
-11% -$230K 0.01% 1194
2025
Q4 		$2M Buy
30,197
+17,694
+142% +$1.14M 0.01% 1075
2025
Q3 		$841K Sell
12,503
-6,750
-35% -$534K ﹤0.01% 1497
2025
Q2 		$1.68M Buy
19,253
+258
+1% +$20.2K 0.01% 1021
2025
Q1 		$1.3M Sell
18,995
-4,910
-21% -$401K 0.01% 1047
2024
Q4 		$1.86M Buy
23,905
+13,159
+122% +$974K 0.01% 858
2024
Q3 		$720K Buy
10,746
+1,726
+19% +$142K ﹤0.01% 1263
2024
Q2 		$1.02M Buy
9,020
+1,393
+18% +$176K 0.01% 1052
2024
Q1 		$1.06M Buy
7,627
+522
+7% +$65.6K 0.01% 975
2023
Q4 		$896K Sell
7,105
-52
-0.7% -$5.31K 0.01% 987
2023
Q3 		$668K Buy
7,157
+2,927
+69% +$330K 0.01% 1048
2023
Q2 		$544K Buy
4,230
+393
+10% +$47.5K 0.01% 1145
2023
Q1 		$446K Sell
3,837
-2,388
-38% -$267K 0.01% 1155
2022
Q4 		$696K Buy
+6,225
New +$683K 0.02% 646
2022
Q1 		– Sell
-6,748
Closed -$906K – 1283
2021
Q4 		$906K Buy
+6,748
New +$970K 0.01% 780
2020
Q4 		– Sell
-5,864
Closed -$604K – 1011
2020
Q3 		$604K Sell
5,864
-6,612
-53% -$691K 0.02% 514
2020
Q2 		$1.26M Buy
12,476
+6,412
+106% +$574K 0.05% 306
2020
Q1 		$408K Sell
6,064
-244
-4% -$15.2K 0.02% 511
2019
Q4 		$344K Sell
6,308
-908
-13% -$43.1K 0.01% 625
2019
Q3 		$283K Buy
+7,216
New +$280K 0.01% 651

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

NewEdge Advisors's DXCM Position: Q2 2026 in Review

NewEdge Advisors increased its DexCom (DXCM) stake by 9.5% in Q2 2026, buying an estimated $171K and bringing the position to 29,455 shares worth $1.98M. The position accounts for 0.01% of the portfolio, ranked #1224.

NewEdge Advisors first reported a position in DXCM in Q3 2019 and has held it in 21 quarters since. The position peaked at $2M in Q4 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • NewEdge Advisors held 29,455 shares of DexCom worth $1.98M as of Q2 2026.
  • NewEdge Advisors bought 2,560 DexCom shares in Q2 2026, an estimated $171K.
  • DexCom made up 0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1224 holding.
  • NewEdge Advisors first reported a position in DexCom in Q3 2019 and has held it in 21 quarters since.
  • NewEdge Advisors's DexCom position peaked at $2M in Q4 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.